ID
32377
Descrizione
This ODM file contains the form for documentation of any concomitant medication. To be assessed at screening and re-assessed at every visit. Study ID: 101199 Clinical Study ID: 101199 Study Title: A randomized, double-blind, parallel group, placebo-controlled, single-attack evaluation of the efficacy and tolerability of TREXIMA™ (sumatriptan 85mg/naproxen sodium 500mg)* tablets vs placebo when administered during the mild pain phase of a migraine Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: sumatriptan Trade Name: Imitrex ,Imiject ,Imigran Study Indication: Migraine Disorders
Keywords
versioni (2)
- 28/10/18 28/10/18 -
- 30/10/18 30/10/18 -
Titolare del copyright
GlaxoSmithKline
Caricato su
28 ottobre 2018
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY-NC 3.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
Efficacy and Tolerability of TREXIMA™ (sumatriptan 85mg/naproxen sodium 500mg) ID 101199
Concomitant Medication
- StudyEvent: ODM
Descrizione
Concomitant Medication
Alias
- UMLS CUI-1
- C2347852 (Concomitant Agent)
Descrizione
MONITOR DATA VALIDATION CHECKS • Check that either ’Yes’ or ’No’ box at the top of the page has been completed. If Yes, record each medication on a separate line using Trade Names where possible. If the medication is related to a Non-Serious Adverse Event or Serious Adverse Event, details should be expressed using the same terminology.
Tipo di dati
text
Alias
- UMLS CUI [1]
- C2347852 (Concomitant Agent)
Descrizione
List of Concomitant Medication
Alias
- UMLS CUI-1
- C2347852 (Concomitant Agent)
Descrizione
MONITOR DATA VALIDATION CHECKS Ensure that the spelling of the Drug Name(s) is correct (use of Trade Names is preferred).
Tipo di dati
text
Alias
- UMLS CUI [1]
- C2360065 (Medication name)
- LOINC
- MTHU027854
Descrizione
MONITOR DATA VALIDATION CHECKS • Ensure that the ’Reason for Medication’ is recorded on one of the following pages using the same terms: • Medical Conditions • Non-Serious Adverse Events • Serious Adverse Events Form
Tipo di dati
text
Alias
- UMLS CUI [1]
- C2826696 (Concomitant Medication Use Indication)
Descrizione
MONITOR DATA VALIDATION CHECKS • Check that either medication start date is completed or ’Taken Prior to Study?’ is ’Yes’. • It is acceptable for start date to be missing if ’Taken Prior to Study?’ is ’Yes’. • It is acceptable if ’Taken Prior to Study?’ is ’Yes’ and a start date is present, as long as the start date is prior to the date of the subject’s initial visit.
Tipo di dati
partialDate
Alias
- UMLS CUI [1]
- C2826734 (Concomitant Medication Start Date)
Descrizione
Taken Prior to Study?
Tipo di dati
text
Alias
- UMLS CUI [1]
- C2826667 (Concomitant Medication Previous Occurrence)
Descrizione
MONITOR DATA VALIDATION CHECKS • Check that either medication stop date is completed or ’Ongoing Medication?’ is ’Yes’. • It is acceptable for stop date to be missing if ’Ongoing Medication?’ is ’Yes’.
Tipo di dati
partialDate
Alias
- UMLS CUI [1]
- C2826744 (Concomitant Medication End Date)
Descrizione
Ongoing Medication
Tipo di dati
text
Alias
- UMLS CUI [1]
- C2826666 (Concomitant Medication Ongoing)
Similar models
Concomitant Medication
- StudyEvent: ODM
Non ci sono commenti